Hemp-derived CBD brands Charlotte’s Web and Infinite Product Co. have both been hit with proposed class action lawsuits filed in California that allege they misled consumers by marketing their products as dietary supplements when FDA has specifically...
The US Food and Drug Administration has stated that it cannot conclude that CBD (cannabidiol) is generally recognized as safe (GRAS) for its use in human food, based on a “lack of scientific information supporting the safety of CBD in food”.
The Court of Appeals for the Eleventh Circuit has paved the way for a potential class action against a supplement brand because of the alleged presence of an illegal ingredient, which rendered the product worthless and gave the plaintiffs standing to...
Defendants in a recent spate of lawsuits alleging discrepancies between the amount of CBD advertised on pack and the amount contained in the products, have hit back in motions to dismiss, with one arguing that such cases should be stayed until the FDA...
Pressure continues to build to find a resolution to the CBD impasse. A trade organization and a state government have filed notices with FDA on the issue.
New Zealand firm Mountain Red has obtained a US ‘sports grade’ certification for its deer velvet antler supplement, after passing assessment by a third party laboratory.
Europe’s Food Safety Authority (EFSA) rules scientific evidence pointing to a white kidney bean extract’s link with body weight reduction as “insufficient,” after the applicant cites application process inconsistencies.
The turmoil surrounding the CBD question has obscured other important debates, such as how to alter DHSEA is such a way that more scientific information can be conveyed to consumers.
An expert panel has recommended an expanded treatment envelope for the EPA drug Vascepa. An expert says the move won’t affect the supplement market directly but does add to recent official recognition of the health benefits of omega-3s.
Introducing user fees for the food industry – of which dietary supplements are a subset – is a tough proposition, says Dan Fabricant, president and CEO of the Natural Products Association.
Germany’s federal government now confirms that cannabidiol (CBD) is to be classified as novel food citing an absence of evidence of its consumption before 15 May 1997.
FDA needs new tools to effectively deal with an expanding supplement marketplace, according to agency official Lowell Schiller. This is especially true when contemplating the flood of CBD products, with many more yet to come.
Cara Welch, PhD has been named deputy director of the Office of Dietary Supplements. Welch replaces Bob Durkin, who recently left FDA for a private law practice.
Before rushing into an amendment of DSHEA it’s wise to consider how the law has already been modified and how full enforcement of those provisions might accomplish what the modification advocates have in mind, a trade organization cautions.
A booming global market with double digit growth rates, establishing an adequate intake for dietary microbes, and why the impending taxonomic changes to the genus Lactobacillus are like Y2K: These were just some of the topics covered during the fourth...
The Botanical Adulterants Prevention Program is nearing the final stage of its initiative to offer industry a way to keep adulterated materials from turning up in finished goods on the shelf.
The case this week of a beverage brand making a supposedly tongue in cheek reference to suicide points to the risks inherent in swinging for the fences in product marketing.
Legislative challenges to dietary supplements and opportunities for regulatory fine tuning continue even as the industry is distracted, said Steve Mister of CRN.
The United States Department of Agriculture has issued its eagerly anticipated draft rule on hemp cultivation. The rule is viewed as largely consistent with many of the state rules already in place.
The 20th annual Oxford International Conference on the Science of Botanicals is now accepting abstract submissions. The event is held March 30th - April 2nd, 2020 in Oxford, Mississippi.
“There’s a new idea emerging that if you have a lot of followers on Instagram and you have a six pack then you are an authority on nutrition and health,” sports nutrition professionals were warned during a nutrition myth-busting conference held in Ireland...
A vast and growing majority of American companies doing business in China have been negatively affected by the US-China trade war, an expert on the matter said at a recent meeting.
A new poll shows many consumers would stop using CBD products if they knew FDA has not yet set regulations around them. The poll was commissioned by the Natural Products Association.
The United Natural Products Alliance has announced a new policy on hemp extracts while at the same time announcing its first member engaged exclusively in the business.
FDA warned pregnant and breast-feeding women yesterday to avoid CBD, THC and marijuana in any form, including the proliferation of food, supplements and cosmetics containing CBD and other cannabis-derived ingredients that currently are flooding the market...
NFL player Brandon Copeland, who had been suspended over a failed drug test, said he plans to file a lawsuit against a company that he claims gave him "contaminated" supplements.
AOAC recognition of two cranberry methods means there is finally consensus on how to identify and quantify the proanthocyanins (PACs) within the botanical, the test’s developer says.
The inauguration of a huge, shiny, new (well, repurposed) facility leads to the question of what scale in the industry best serves the dietary supplement consumer.
New Trump Administration executive orders on guidance documents from regulatory agencies likely will affect the dietary supplement industry, an attorney says.
Early data on the Food Safety Modernization Act suggests the new law is working as compliance is improving and recalls have hit a five year low. A newly launched web portal will help track that data.
The International Probiotics Association will host its fourth IPA DC Workshop with insights from a range of experts and stakeholders, including the FDA/ CFSAN, FTC, and Health Canada. The event is held in conjunction with the US Pharmacopeia.
Yesterday four trade associations representing the dietary supplement industry sent a letter to all 535 members of the US Congress urging them to make CBD a legal dietary ingredient and to give FDA the resources to regulate the sector.
FDA is continuing to crack down on the legality of CBD when a case comes across its desk, despite a call for an official enforcement discretion policy.
French consulting firm Nutraveris has launched two AI platforms aimed at helping American firms streamline entry into the markets of EU member countries.
President Trump is poised to nominate Oncologist Dr. Stephen Hahn to head the Food and Drug Administration, pending completion of the vetting process, several news outlets are reporting.
AdvoCare, a multi-level marketing company, has agreed to a $150 million fine and a compensation plan restructuring to settle an FTC pyramid scheme case. In addition, the former CEO has agreed to a ban from the industry.
A new Pew survey on dietary supplements found that 1 in 8 consumers said they or a family member had experienced an adverse event, a finding which has been criticized as a faulty statistic.
CVS has agreed to pay refunds on a brand of memory supplements, according to the Center for Science in the Public Interest, which had sued the company on behalf of consumers.
Herbalife Nutrition has agreed to pay a $20 million fine levied by the US Securities and Exchange Commission to settle a claim that the company has misled investors on its business in China.
The US House of Representatives is expected to vote today on a bill that would clear the way for full banking services for companies dealing in hemp/CBD products.
‘Natural’ doesn’t always mean ‘safe’, and often herbal and botanical supplements have their share of side-effects, especially when combined with medications.
NSF International has unveiled a new certification program for the hemp industry, which the organization says will help address the ongoing quality questions in this sector.
Foods for special medical purposes (FSMP), functional foods, and ease of convenience are three emerging categories that dietary supplements and pharma companies are paying attention to, according to Mintel.